Related Experiment Video
Updated: Jul 7, 2025

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
The Current Treatment Landscape of Malignant Pleural Mesothelioma and Future Directions
Beatriz Bertin1, Miguel Zugman2, Gustavo Schvartsman2
1Faculdade Israelita de Ciências da Saúde Albert Einstein, Hospital Israelita Albert Einstein, São Paulo 05651-901, Brazil.
Abstract:
The incidence of malignant pleural mesothelioma is expected to increase globally. New treatment options for this malignancy are eagerly awaited to improve the survival and quality of life of patients. The present article highlights the results of recent advances in this field, analyzing data from several relevant trials. The heterogeneous tumor microenvironment and biology, together with the low mutational burden, pose a challenge for treating such tumors. So far, no single biomarker has been soundly correlated with targeted therapy development; thus, combination strategies are often required to improve outcomes. Locally applied vaccines, the expansion of genetically engineered immune cell populations such as T cells, the blockage of immune checkpoints that inhibit anti-tumorigenic responses and chemoimmunotherapy are among the most promising options expected to change the mesothelioma treatment landscape.
Insights
New treatments for malignant pleural mesothelioma are emerging, including vaccines, engineered T cells, and chemoimmunotherapy, to combat this challenging cancer and improve patient survival.
Area of Science:
- Oncology
- Immunotherapy
- Cancer Biology
Background:
- Malignant pleural mesothelioma incidence is rising globally.
- Current treatment options are limited, necessitating novel approaches.
- Tumor heterogeneity and low mutational burden present therapeutic challenges.
Purpose of the Study:
- To review recent advances in malignant pleural mesothelioma treatment.
- To analyze data from relevant clinical trials.
- To highlight promising future therapeutic strategies.
Main Methods:
- Review of recent clinical trials and research data.
- Analysis of treatment efficacy and challenges.
- Identification of emerging therapeutic modalities.
Main Results:
- No single biomarker is established for targeted therapy.
- Combination strategies are often necessary for improved outcomes.
- Promising options include locally applied vaccines, engineered T cells, and immune checkpoint blockade.
Conclusions:
- Advances in immunotherapy and chemoimmunotherapy show promise for mesothelioma.
- Combination strategies are crucial for overcoming treatment resistance.
- These novel approaches are expected to significantly alter the mesothelioma treatment landscape.
More Related Videos
Related Concept Videos
Pleural Disorders: Types and Brief Description
Targeted Cancer Therapies
There are several types of targeted therapies against...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleura of the Lungs

